학술논문
PO.1.1 Afimetoran, a potent and selective inhibitor of human toll-like receptor 7 (TLR7) and tlr8, provides robust efficacy in a murine lupus model of advanced disease
Document Type
article
Author
Source
Lupus Science and Medicine, Vol 9, Iss Suppl 2 (2022)
Subject
Language
English
ISSN
2053-8790